Arrowhead Research | ARWR - Lieferungen Und Leistungen

Aktienkurs
72.87
Täglich Wechseln
2.34 3.32%
Monatlich
16.22%
Jährlich
419.02%
Q2 Prognose
72.33




Lieferungen Und Leistungen Veränderung Datum
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 32.94M 15.26M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
Merck USD 4.4B 257M 2025-12
Moderna USD 317M 50M 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.46B 99M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xencor USD 10.83M 1.75M 2025-12